Inflammatory Bowel DiseaseJoseph B. Kirsner, Roy Gerrard Shorter |
From inside the book
Results 1-3 of 75
Page 274
... therapy to avoid adrenal insufficiency . If toxic dilatation , with or without perforation , develops in a patient who discontinued steroid therapy within six months of the attack , such therapy should be reinstituted in full therapeutic ...
... therapy to avoid adrenal insufficiency . If toxic dilatation , with or without perforation , develops in a patient who discontinued steroid therapy within six months of the attack , such therapy should be reinstituted in full therapeutic ...
Page 491
... therapy . Although most experience has been with azathioprine and 6 - mercaptopu- rine , the potential role of cyclosporine has yet to be established.2 263-266 * Miscellaneous Therapeutic Approaches Immunostimulants 267 Cell - mediated ...
... therapy . Although most experience has been with azathioprine and 6 - mercaptopu- rine , the potential role of cyclosporine has yet to be established.2 263-266 * Miscellaneous Therapeutic Approaches Immunostimulants 267 Cell - mediated ...
Page 529
... therapy . ' On the other hand , medical therapy of Crohn's disease ( CD ) is less effective . Although up to 70 % of patients with CD respond favorably to short - term ( 4 months ) therapy with drugs such as corticosteroids , a sharp ...
... therapy . ' On the other hand , medical therapy of Crohn's disease ( CD ) is less effective . Although up to 70 % of patients with CD respond favorably to short - term ( 4 months ) therapy with drugs such as corticosteroids , a sharp ...
Contents
Clinical Features Laboratory | 9 |
Experimental Inflammatory | 45 |
Intestinal Microflora | 55 |
Copyright | |
19 other sections not shown
Common terms and phrases
abdominal abscess acid activity acute antibodies antigens appear associated biopsy blood cancer carcinoma cause cells changes chronic Clin clinical colectomy colon common complexes complications continued corticosteroids course Crohn's disease develop diagnosis diarrhea dose drug ease effects enema enteritis et al evidence examination extensive factors findings fistula frequently function Gastroenterol Gastroenterology growth human ileostomy ileum immune important incidence increased indicated inflam inflammatory bowel disease involvement lesions less levels loss lymphocytes ment mucosa normal noted nutrition obstruction occur operation oral pain patients with Crohn's possible present rectal rectum recurrence regional reported require resection response risk role Scand seen serum severe showed small intestine specific steroids strictures suggest sulfasalazine Surg surgical symptoms Table therapy tients tion tissue tive toxic tract treated treatment ulcerative colitis usually